Australian-based and globally integrated biopharmaceutical company, Immuron Ltd (NASDAQ:IMRN, ASX:IMC), will present at The Military Health System Research.
Microbion Corporation today announced that the company will be presenting a poster that highlights key clinical study design elements from an ongoing phase 2 study assessing safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers at the 2023 Military Health System Research Symposium being held from August 14th to 17th, 2023, at the Gaylord Palms Resort and Convention Center in Kissimmee, FL. This Phase 2 study is fun
MELBOURNE, Australia, Aug. 14, 2023 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it will be presenting
Taking a Bite Out of Malaria: School of Medicine Works to Control Spread of the Disease Across the Globe umaryland.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umaryland.edu Daily Mail and Mail on Sunday newspapers.
NASA Spaceline Current Awareness List #1,055 23 June 2023 (Space Life Science Research Results) spaceref.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spaceref.com Daily Mail and Mail on Sunday newspapers.